Condition
MGMT-Methylated Glioblastoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 MGMT-Methylated Glioblastoma clinical trials that are recruiting, at sites in 5 countries (most in United States (3), Austria (1), Denmark (1)). By phase: Phase 2 (2), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest MGMT-Methylated Glioblastoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adding ruxolitinib to standard radiation and temozolomide for newly diagnosed glioblastoma | Phase 2 | Miami, Florida and 1 other locations | Recruiting | May 25, 2025 |
| G-CSF after chemo-radiation for MGMT-methylated glioblastoma | Phase 2 | Boston, Massachusetts | Recruiting | Oct 21, 2024 |
| Combination of DB107-RRV, DB107-FC, and radiation therapy for high grade glioma | Phase 1/2 | Los Angeles, California and 4 other locations | Recruiting | Jul 16, 2024 |
| Adding lomustine to standard care for MGMT‑methylated glioblastoma | Phase 3 | Graz and 19 other locations | Recruiting | May 17, 2024 |
All recruiting trials (4)
-
Adding ruxolitinib to standard radiation and temozolomide for newly diagnosed glioblastoma
This trial will try whether adding the oral drug ruxolitinib to standard radiation and temozolomide helps adults newly diagnosed with glioblastoma.
-
G-CSF after chemo-radiation for MGMT-methylated glioblastoma
This test checks whether giving G-CSF after standard chemo-radiation helps protect brain structure and thinking in adults with newly diagnosed MGMT-methylated glioblastoma.
-
Combination of DB107-RRV, DB107-FC, and radiation therapy for high grade glioma
This study is testing a new combination of treatments for people with newly diagnosed high grade glioma to see if it helps them live longer without their cancer getting worse after surgery.
-
Adding lomustine to standard care for MGMT‑methylated glioblastoma
This trial tests whether giving lomustine together with temozolomide and radiation helps adults with newly diagnosed, MGMT‑methylated, IDH‑wildtype glioblastoma live longer.
Related topics
Quick answers
How many MGMT-Methylated Glioblastoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), Austria (1 trial), Denmark (1 trial), Norway (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.